NTHI NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. (NTHI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: September 11, 2026 , by Heshmatpour Amir F .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | CEO, President | Buy | 37,000 | $3.67 | $135.6K | 3,133,000 | |
| CHEN THOMAS C | CEO | Buy | 12,757 | $5.49 | $70.0K | 13,705 | |
| Heshmatpour Amir F | CEO, President | Buy | 9,000 | $5.54 | $49.9K | 3,096,000 | |
| Heshmatpour Amir F | CEO, President | Buy | 3,000 | $4.37 | $13.1K | 3,087,000 | |
| CHEN THOMAS C | CEO | Buy | 2,472 | $4.04 | $10.0K | 583,531 | |
| CHEN THOMAS C | Chief Scientific Officer | Buy | 2,472 | $4.04 | $10.0K | 583,531 | |
| CHEN THOMAS C | CEO | Buy | 33,787 | $3.85 | $130.0K | 581,059 | |
| CHEN THOMAS C | Chief Scientific Officer | Buy | 33,787 | $3.85 | $130.0K | 581,059 | |
| Heshmatpour Amir F | CEO, President | Buy | 12,000 | $3.79 | $45.5K | 3,084,000 | |
| Heshmatpour Amir F | President | Buy | 10,000 | $4.16 | $41.6K | 3,072,000 | |
| Heshmatpour Amir F | President | Buy | 10,000 | $4.52 | $45.2K | 3,062,000 | |
| CHEN THOMAS C | Chief Scientific Officer | Buy | 10,000 | $4.80 | $48.0K | 10,000 | |
| Heshmatpour Amir F | President | Buy | 10,000 | $4.90 | $49.0K | 3,052,000 | |
| Neman-Ebrahim Yousha | Chief Clinical Officer | Buy | 500 | $4.88 | $2.4K | 134,760 | |
| Heshmatpour Amir F | President | Buy | 10,000 | $4.89 | $49.0K | 3,042,000 | |
| CHEN THOMAS C | Chief Scientific Officer | Buy | 948 | $5.17 | $4.9K | 948 | |
| Heshmatpour Amir F | President | Buy | 5,000 | $5.19 | $26.0K | 3,032,000 | |
| SUH, DAVID JR. | Chief Accounting Officer | Buy | 200 | $5.00 | $1.0K | 111,866 | |
| Heshmatpour Amir F | President | Buy | 10,000 | $5.61 | $56.1K | 3,027,000 | |
| Heshmatpour Amir F | President | Buy | 5,000 | $6.32 | $31.6K | 3,017,000 | |
| Heshmatpour Amir F | President | Buy | 20,000 | $6.09 | $121.8K | 3,012,000 | |
| Heshmatpour Amir F | President | Buy | 6,000 | $6.51 | $39.1K | 2,992,000 | |
| Heshmatpour Amir F 2 fills | President | Buy | 24,000 | $6.07 | $145.6K | 2,986,000 | |
| Neman-Ebrahim Yousha | Chief Clinical Officer | Buy | 1,100 | $6.69 | $7.4K | 134,260 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.